AU513066B2 - 3 amino-2hydroxy-propoxphenyl derivatives - Google Patents

3 amino-2hydroxy-propoxphenyl derivatives

Info

Publication number
AU513066B2
AU513066B2 AU25140/77A AU2514077A AU513066B2 AU 513066 B2 AU513066 B2 AU 513066B2 AU 25140/77 A AU25140/77 A AU 25140/77A AU 2514077 A AU2514077 A AU 2514077A AU 513066 B2 AU513066 B2 AU 513066B2
Authority
AU
Australia
Prior art keywords
compound
carbon atoms
formula
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25140/77A
Other languages
English (en)
Other versions
AU2514077A (en
Inventor
R. and Payne T. G Berthold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU2514077A publication Critical patent/AU2514077A/en
Application granted granted Critical
Publication of AU513066B2 publication Critical patent/AU513066B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU25140/77A 1976-05-14 1977-05-13 3 amino-2hydroxy-propoxphenyl derivatives Expired AU513066B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CHCH6063/76 1976-05-14
CH606376A CH621330A5 (enExample) 1976-05-14 1976-05-14

Publications (2)

Publication Number Publication Date
AU2514077A AU2514077A (en) 1978-11-16
AU513066B2 true AU513066B2 (en) 1980-11-13

Family

ID=4303639

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25140/77A Expired AU513066B2 (en) 1976-05-14 1977-05-13 3 amino-2hydroxy-propoxphenyl derivatives

Country Status (26)

Country Link
US (1) US4322437A (enExample)
JP (1) JPS52139051A (enExample)
AT (1) AT362349B (enExample)
AU (1) AU513066B2 (enExample)
BE (1) BE854567A (enExample)
CA (1) CA1095913A (enExample)
CH (1) CH621330A5 (enExample)
CY (1) CY1226A (enExample)
DE (1) DE2719871A1 (enExample)
DK (1) DK197677A (enExample)
ES (1) ES458724A1 (enExample)
FI (1) FI771427A7 (enExample)
FR (1) FR2351091A1 (enExample)
GB (1) GB1576034A (enExample)
HK (1) HK35984A (enExample)
IE (1) IE44950B1 (enExample)
IL (1) IL52072A (enExample)
KE (1) KE3405A (enExample)
NL (1) NL7705128A (enExample)
NZ (1) NZ184079A (enExample)
PH (1) PH14176A (enExample)
PT (1) PT66540B (enExample)
SE (1) SE7705221L (enExample)
SG (1) SG84983G (enExample)
SU (1) SU634663A3 (enExample)
ZA (1) ZA772873B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2810869A1 (de) * 1977-03-24 1978-09-28 Sandoz Ag 3-amino-2-hydroxypropoxy-derivate, ihre herstellung und verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641152A (en) * 1949-07-15 1953-06-09 Herbert M Hise Stringed musical instrument
GB1046001A (en) * 1964-03-12 1966-10-19 Ici Ltd Propanolamine derivatives
US3839415A (en) * 1965-10-22 1974-10-01 Lilly Co Eli 2-halo-1-(alkyl-1-(alkylamino)ethyl)vinyl benzoic acid esters and derivatives
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
CH554314A (de) * 1969-06-03 1974-09-30 Sandoz Ag Verfahren zur herstellung neuer fluorenone.
BE755071A (fr) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Also Published As

Publication number Publication date
HK35984A (en) 1984-05-04
PT66540B (fr) 1979-10-22
CA1095913A (en) 1981-02-17
DE2719871A1 (de) 1977-12-01
FR2351091B1 (enExample) 1980-01-18
ES458724A1 (es) 1978-08-01
DK197677A (da) 1977-11-15
US4322437A (en) 1982-03-30
AT362349B (de) 1981-05-11
IE44950L (en) 1977-11-14
GB1576034A (en) 1980-10-01
IE44950B1 (en) 1982-05-19
IL52072A0 (en) 1977-07-31
SU634663A3 (ru) 1978-11-25
FI771427A7 (enExample) 1977-11-15
PH14176A (en) 1981-03-19
CY1226A (en) 1984-04-06
NL7705128A (nl) 1977-11-16
SG84983G (en) 1985-01-11
CH621330A5 (enExample) 1981-01-30
PT66540A (fr) 1977-06-01
NZ184079A (en) 1978-09-25
FR2351091A1 (fr) 1977-12-09
IL52072A (en) 1980-10-26
BE854567A (fr) 1977-11-14
AU2514077A (en) 1978-11-16
JPS52139051A (en) 1977-11-19
KE3405A (en) 1985-02-01
ZA772873B (en) 1978-12-27
ATA343577A (de) 1980-10-15
SE7705221L (sv) 1977-11-15

Similar Documents

Publication Publication Date Title
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU2902577A (en) 4-n-acylfortimicin b derivatives
AU508171B2 (en) 4 hydroxy-aporphine derivatives
AU517829B2 (en) Morphanthridine derivatives
AU504526B2 (en) Pipeazine derivatives
AU508791B2 (en) Indazolyl-(4)-oxypropanolamine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU506573B2 (en) 3'phenoxybenzyl-l-phenyl-cyclobutane-l-carboxylate derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU511784B2 (en) Seldomycin factor 5 derivatives
AU512647B2 (en) Solpenamide derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU540464B2 (en) Morphanthridine derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives
AU512688B2 (en) Thienyl-and T-aminophenyl-pyrrolidine derivatives
AU495377B2 (en) 3-nitropyrazole derivatives